Back to User profile » Ms Victoria Carter

Papers published by Ms Victoria Carter:


A 21-Practice Evaluation of an Asthma and COPD Quality Improvement Program

Blakey JD, Bosnic-Anticevich S, Cvetkovski B, Hancock KL, Le Cheng P, Tyrer F, Townend J, Hew M, Del Fante P, Ranasinghe K, Thompson PJ, Smith PK, Soumakiyan M, Stewart D, Sharma A, Willet B, Abutalieva-Lechner K, Le Lievre C, Roussos A, Accalai ​ P, Botini F, Bushell N, Carter V, Le T, Price D

Journal of Asthma and Allergy 2025, 18:1599-1613

Published Date: 11 November 2025

Predicting Risk of Morbidities Associated with Oral Corticosteroid Prescription for Asthma

Stanley B, Chapaneri J, Khezrian M, Maslova E, Patel S, Gurnell M, Canonica GW, Reddel HK, Heaney LG, Bourdin A, Neil DL, Carter V, Price DB

Pragmatic and Observational Research 2025, 16:95-109

Published Date: 25 March 2025

Real-World Biologic Use Patterns in Severe Asthma, 2015–2021: The CLEAR Study

Tran TN, Chen S, Emmanuel B, Altraja A, Bourdin A, Sheu CC, Tsai MJ, Hoyte FC, Quinton A, Cook B, Bulathsinhala L, Henley W, Goh CYY, Liu Y, Ariti C, Carter V, Price DB

Pragmatic and Observational Research 2025, 16:51-66

Published Date: 18 March 2025

Preserved Ratio Impaired Spirometry in US Primary Care Patients Diagnosed with Chronic Obstructive Pulmonary Disease

Evans A, Tarabichi Y, Pace WD, Make B, Bushell N, Carter V, Chang KL, Fox C, Han MK, Kaplan A, Kocks JWH, Le Lievre C, Roussos A, Skolnik N, Soriano JB, Yawn BP, Price D

Pragmatic and Observational Research 2024, 15:221-232

Published Date: 13 December 2024

Budesonide/Glycopyrrolate/Formoterol for the Management of COPD in a UK Primary Care Population: Real-World Use and Early Medication Success

Müllerová H, Chan JSK, Heatley H, Carter V, Townend J, Skinner D, Franzén S, Marshall J, Price D

International Journal of Chronic Obstructive Pulmonary Disease 2024, 19:1153-1166

Published Date: 24 May 2024

Data-Resource Profile: United Kingdom Optimum Patient Care Research Database

Lynam A, Curtis C, Stanley B, Heatley H, Worthington C, Roberts EJ, Price C, Carter V, Dennis J, McGovern A, Price D

Pragmatic and Observational Research 2023, 14:39-49

Published Date: 27 April 2023

Patients with Chronic Obstructive Pulmonary Disease and Evidence of Eosinophilic Inflammation Experience Exacerbations Despite Receiving Maximal Inhaled Maintenance Therapy

Chen S, Miravitlles M, Rhee CK, Pavord ID, Jones R, Carter V, Emmanuel B, Alacqua M, Price DB

International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:2187-2200

Published Date: 9 September 2022

Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone [Corrigendum]

Price DB, Henley W, Cançado JED, Fabbri LM, Kerstjens HA, Papi A, Roche N, Şen E, Singh D, Vogelmeier CF, Barille S, Nudo E, Carter V, Skinner D, Vella R, Georges G

International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:489-490

Published Date: 7 March 2022

Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone

Price DB, Henley W, Cançado JED, Fabbri LM, Kerstjens HA, Papi A, Roche N, Şen E, Singh D, Vogelmeier CF, Barille S, Nudo E, Carter V, Skinner D, Vella R, Georges G

International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:355-370

Published Date: 15 February 2022

Association Between a Type 2 Inflammatory Disease Burden Score and Outcomes Among Patients with Asthma

Price D, Menzies-Gow A, Bachert C, Canonica GW, Kocks J, Khan AH, Ye F, Rowe PJ, Lu Y, Kamat S, Carter V, Voorham J

Journal of Asthma and Allergy 2021, 14:1173-1183

Published Date: 29 September 2021

Persistence of Eosinophilic Asthma Endotype and Clinical Outcomes: A Real-World Observational Study

Tran TN, Kerkhof M, Carter V, Price DB

Journal of Asthma and Allergy 2021, 14:727-742

Published Date: 25 June 2021

Physiological predictors Of peak inspiRatory flow using Observed lung function resultS (POROS): evaluation at discharge among patients hospitalized for a COPD exacerbation

Price DB, Yang S, Wan Yau Ming S, Hardjojo A, Cabrera C, Papaioannou AI, Loukides S, Kritikos V, Bosnic-Anticevich SZ, Carter V, Dorinsky PM

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:3937-3946

Published Date: 13 December 2018